Jane Street’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.26M Sell
22,300
-59,900
-73% -$3.9M ﹤0.01% 6024
2025
Q4
$6.59M Sell
82,200
-29,200
-26% -$1.96M ﹤0.01% 2837
2025
Q3
$5.43M Buy
111,400
+33,000
+42% +$2.04M ﹤0.01% 3307
2025
Q2
$5.85M Sell
78,400
-2,500
-3% -$166K ﹤0.01% 2796
2025
Q1
$5.14M Sell
80,900
-35,400
-30% -$2.41M ﹤0.01% 2895
2024
Q4
$9.08M Buy
116,300
+36,500
+46% +$2.93M ﹤0.01% 1976
2024
Q3
$6.41M Buy
79,800
+200
+0.3% +$16.2K ﹤0.01% 2470
2024
Q2
$6.59M Buy
+79,600
New +$7M ﹤0.01% 2581
2024
Q1
Sell
-5,300
Closed -$453K 9548
2023
Q4
$453K Buy
+5,300
New +$458K ﹤0.01% 6929
2023
Q1
Sell
-3,500
Closed -$275K 9377
2022
Q4
$275K Sell
3,500
-4,400
-56% -$354K ﹤0.01% 7161
2022
Q3
$585K Sell
7,900
-100
-1% -$7.18K ﹤0.01% 6394
2022
Q2
$521K Buy
8,000
+1,500
+23% +$88.8K ﹤0.01% 6660
2022
Q1
$411K Sell
6,500
-12,400
-66% -$674K ﹤0.01% 7839
2021
Q4
$1M Sell
18,900
-15,200
-45% -$926K ﹤0.01% 5885
2021
Q3
$2.41M Buy
34,100
+2,200
+7% +$139K ﹤0.01% 4093
2021
Q2
$2.13M Sell
31,900
-46,100
-59% -$3.26M ﹤0.01% 4220
2021
Q1
$8.66M Buy
+78,000
New +$9.65M ﹤0.01% 1698
2020
Q4
Sell
-45,900
Closed -$4M 7724
2020
Q3
$4M Buy
+45,900
New +$4.01M ﹤0.01% 2103

Other funds holding HAE

Jane Street's HAE Position: Q1 2026 in Review

Jane Street reduced its Haemonetics (HAE) stake by 71% in Q1 2026, selling an estimated $24.3M and leaving 152,958 shares worth $8.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2725.

Jane Street first reported a position in HAE in Q4 2013 and has held it in 30 quarters since. The position peaked at $42.2M in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Jane Street held 152,958 shares of Haemonetics worth $8.62M as of Q1 2026.
  • Jane Street sold 373,329 Haemonetics shares in Q1 2026, an estimated $24.3M.
  • Haemonetics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #2725 holding.
  • Jane Street first reported a position in Haemonetics in Q4 2013 and has held it in 30 quarters since.
  • Jane Street's Haemonetics position peaked at $42.2M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.